Global Human Rabies Vaccine Market Growth 2023-2029

Global Human Rabies Vaccine Market Growth 2023-2029

Rabies Vaccine is an immunization drug used to prevent rabies in people who have been bitten by an animal or otherwise exposed to the rabies virus.
There are a number of rabies vaccines available that are both safe and effective. They can be used to prevent rabies, before or after exposure to the rabies virus, which is commonly caused by a dog bite or a bat bite.
LPI (LP Information)' newest research report, the “Human Rabies Vaccine Industry Forecast” looks at past sales and reviews total world Human Rabies Vaccine sales in 2022, providing a comprehensive analysis by region and market sector of projected Human Rabies Vaccine sales for 2023 through 2029. With Human Rabies Vaccine sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Human Rabies Vaccine industry.
This Insight Report provides a comprehensive analysis of the global Human Rabies Vaccine landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Human Rabies Vaccine portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms' unique position in an accelerating global Human Rabies Vaccine market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Human Rabies Vaccine and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Human Rabies Vaccine.
The global Human Rabies Vaccine market size is projected to grow from US$ 1033 million in 2022 to US$ 1402.1 million in 2029; it is expected to grow at a CAGR of 1402.1 from 2023 to 2029.
Global Human Rabies Vaccine market leaders include Chengda Bio, Bharat Biotech, Bavarian Nordic, Sanofi-Pasteur, etc. All of the above hold over 65 percent market share.
Asia-Pacific is the largest consumption area, with a consumption market share close to 60%. Besides, North Americas is the second largest consumption area with a consumption market share of over 15%.
The classification of Human Rabies Vaccine includes Vero Cell, BHK, Chick Embryo Cell, Human Diploid Cells, and Others. In addition, the proportion of Vero Cell rabies vaccines is about 85%.
Human Rabies Vaccine is widely used for Pre-exposure and Post-exposure. The segment of Human Rabies Vaccine used for Post-exposure and the market share is over 70% of the share.
This report presents a comprehensive overview, market shares, and growth opportunities of Human Rabies Vaccine market by product type, application, key manufacturers and key regions and countries.
Market Segmentation:
Segmentation by type
Vero Cell
BHK
Chick Embryo Cell
Human Diploid Cells
Others
Segmentation by application
Pre-Exposure Vaccine
Post-Exposure Vaccine
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Bharat Biotech
Bavarian Nordic
Sanofi-Pasteur
Chengda Bio
KANGH
Prcmise
Henan Grand Biopharma
Zhuoyi Biological
ZhongKe Biopharm
Ningbo Rongan Biological
Indian Immunologicals

Key Questions Addressed in this Report
What is the 10-year outlook for the global Human Rabies Vaccine market?
What factors are driving Human Rabies Vaccine market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Human Rabies Vaccine market opportunities vary by end market size?
How does Human Rabies Vaccine break out type, application?
What are the influences of COVID-19 and Russia-Ukraine war?

Please note: The report will take approximately 2 business days to prepare and deliver.